Maurizio Tassi - MolMed S Insider

MolMed S p A -- Germany Stock  

EUR 0.39  0.01  2.63%

Non-Executive Director

Dr. Maurizio Tassi serves as a NonExecutive Director of Molecular Medicine S.p.A. since November 6 2007. He was a Member of the Audit and Risk Management Committee of the Company since November 6 2007. He has worked for 20 years in the investment banking sector for various companies including NewSmith Capital Partners Citigroup Schroders and CredianstaltBankverein and specialized in capital markets and capital increases. He has experience in the pharmaceutical sector. He was involved in the privatization of Gedeon Richter in Hungary in the dual listing in Switzerland and North America of Biomarin Pharmaceuticals and Amplifon. He also serves as Sole Director of Tassi Limited. He gained a degree in Anthropology from the University of London and a MS in Economics from the University of London.
Age: 54  Director Since 2007      

Management Efficiency

The company has return on total asset (ROA) of (18.1) % which means that it has lost $18.1 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (61.21) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 964 K in total debt with debt to equity ratio (D/E) of 6.1 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. MolMed S p A has Current Ratio of 1.37 which is within standard range for the sector.

Similar Executives

Entity Summary

MolMed S p A (4HW) is traded on Frankfurt Stock Exchange in Germany. and employs 23 people.

Did you try this?

Run Bollinger Bands Now
   

Bollinger Bands

Use Bollinger Bands indicator to analyze target price for a given investing horizon
Hide  View All  Next  Launch Bollinger Bands
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add MolMed S p A to your portfolio

Top Management

MolMed S p Leadership Team
Gian Rizzardi, Director, Ph.D
Marina Bue, Director
Didier Trono, Director
Silvia Pisante, Executive
Mario Masciocchi, Director
Carlo Incerti, Director
Raffaella Ruggiero, Director
Holger Neecke, Director
Luca Alberici, Executive
Maurizio Tassi, Director
Daniele Pieraccioli, Director, Ph.D
Alberto Carletti, Director
Laura Ferro, Director
Marco Dieci, Director, Ph.D
Catia Traversari, Director, Ph.D
Lorenzo Salieri, Director
Elizabeth Robinson, Director
Riccardo Palmisano, CEO
Sabina Grossi, Director, Ph.D
Alfredo Messina, Director
Monica Masolo, Director
Germano Carganico, Executive, Ph.D
Claudio Bordignon, Chairman, Ph.D
Gianluigi Fiorendi, Director
Andrea Quaglino, Director
Khalid Islam, Director, Ph.D
Laura Villa, Director
Cynthia Giuliani, Director
Antonio Lambiase, Director, Ph.D
Marco Manoni, Director
Tiziano Andreoli, Director

Stock Performance

MolMed S Performance Indicators